Steven F Bolling Professor of Cardiac Surgery University of Michigan

Similar documents
I have financial relationships to disclose Honoraria from: Edwards

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Concomitant Tricuspid Valve Repair :

Understanding the guidelines for Interventions in MR. Ali AlMasood

Techniques for ischemic mitral valve disease: An Update. Stanford CV Surgery

Prognostic Impact of FMR

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT

Functional Ischaemic Mitral Regurgitation: CABG + MV Replacement. Prakash P Punjabi. FRCS(Eng),FESC,MS,MCh,FCCP, Diplomate NBE

Percutaneous technologies to correct TR : Myth or Reality? Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Mitral valve treatment in advanced heart failure: Repair, Replacement, MitraClip. Nicola Buzzatti, MD San Raffaele Scientific Institute Milan, Italy

Surgical repair techniques for IMR: future percutaneous options?

Functional Mitral Regurgitation; therapeutic continuum overview. Michele Senni. Cardiologia 1 Scompenso e Trapianti di Cuore A.O. PAPA GIOVANNI XXIII

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Surgical Approach To Functional MR: One Size Does Not Fit All

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today?

Percutaneous Mitral Valve Repair

Ischemic Mitral Regurgitation

Catheter-based mitral valve repair MitraClip System

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

Management of Tricuspid Regurgitation

Burden of Mitral Regurgitation (MR) in the US Why is This Important?

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

The HRT Mitral Bridge Technology for Functional MR

Percutaneous Mitral Valve Repair

Chronic Primary Mitral Regurgitation

Τελικά επιδιόρθωση, αντικατάσταση ή clip στην ισχαιμική ανεπάρκεια Μιτροειδούς; ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Mitral Regurgitation

Treatment options in ischaemic mitral regurgitation: surgery, clips, devices?

Valvular Intervention

Mitral Valve Disease, When to Intervene

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Index. B B-type natriuretic peptide (BNP), 76

Repair or Replacement

Valvular Guidelines: The Past, the Present, the Future

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

What is the Role of Surgical Repair in 2012

Functional Mitral Regurgitation

The Mitral Revolution: Transcatheter Repair (and Replacement?) Going Mainstream

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Percutaneous Repair for MR:

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Percutaneous Mitral Valve Intervention: QuantumCor Device

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

Ischemic Mitral Regurgitation

TrattamentoTrans-catetere dell insufficienza mitralica. Francesco Bedogni. Istituto Clinico S. Ambrogio, Milano

Transcatheter Mitral Valve Repair: today and tomorrow Sponsored by Abbott. Chairperson: M. Haude Panellists: A. Al Nooryani, M.

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

Introducing the COAPT Trial

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Mitral Valve Disease. James Hermiller, MD, FACC, FSCAI St Vincent Heart Center Indianapolis, IN

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

MitraClip: Why, How, and For Whom?

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Use of MitraClip Beyond Everest Criteria

What Is the Role of Mitral Repair in Heart Failure?

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Surgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan

Transcatheter Mitral Valve for fmr: The Era of Too Many Options

MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR RESTORATION

Mitral club: From clinical practice to guidelines: the world upside down

Secondary Mitral Regurgitation: When Should We Intervene?

Imaging to select patients for Transcatheter TV

Mitral Valve Repair for Functional Mitral Regurgitation in End-Stage Dilated Cardiomyopathy Role of the Edge-to-Edge Technique

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Management of Secondary MR : Insights from CTSN Ischemic MR trial; COAPT and MITRA-FR:

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Imaging in dilated cardiomyopathy : factors associated with a poor outcome

Management of HOCM: Non-Surgical Options

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

(Ann Thorac Surg 2008;85:845 53)

What echo measurements are key prior to MitraClip?

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

Ischemic mitral regurgitation (IMR) is an insufficiency of

Management of High-Risk CAD : Surgeons Perspective

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA

Current status: Percutaneous mitral valve therapy

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

GDMT for percutaneous mitral valve repair

Treatment for functional mitral regurgitation

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT VS. REPAIR: COMPETITION OR SYNERGY

Transcription:

Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan

Functional MR

Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure, 2004

FMR : Ventricular Problem!! Badhwar, Bolling, chapter in: Advances in Heart Failure, 2004

Optimal Medical Therapy of FMR 1.0 : survival is not optimal! 0.8 surv vival 0.6 0.4 0.2 0.0 MR grade No. None 9,405 Mild 2,062 Moderate 210 Severe 171 0 1 2 3 4 5 Years Hickey et al: Circulation 78:1-51, 1988

In fact, even with small amounts of FMR it s terrible!! ERO RVol Grigioni et al: Circulation 103:1759, 2001

In 2012, with the modern testing & treatment they still do very badly! Szymanski et al Am J Cardiol 2011 Sep 21.

MR - Prognostic value 1300 CHF / FMR Mean age 67, mean EF 32% NYHA I 150 (15%) II 500 (49%) III 316 (31%) IV 57 (6%) Mean fu 2.7y Severe MR 24% Mild or Moderate MR 49% No MR 27% Rossi et al Heart 2011; 97:1675-80

More MR is worse! Ischemic or Dilated Rossi A et al. Heart 2011;97:1675-1680 2011 by BMJ Publishing Group Ltd and British Cardiovascular Society

FMR Not just a late marker! FMR worsened odds ratio of death Rossi A et al. Heart 2011;97:1675-1680 2011 by BMJ Publishing Group Ltd and British Cardiovascular Society

CRT for FMR : Less than half eligible, of which less than half respond van Bommel R J et al. Circulation 2011;124:912-919 Residual MR is still BAD!! Copyright American Heart Association

Undersized Mitral Repair for FMR Nyah, Nyah! Surgeons can fix FMR!!

Mitral Repair for FMR in CHF Bolling Chen Bishay Calafiore Buffolo Bitran Dreyfus Suma ACORN JTCVS 1995 200 pts Circ 1998 81 pts Eur JCTS 2000 44 pts Ann TS 2000 49 pts Ar Br Card 2000 80 pts J Card Surg 2001 21 pts JHLT 2000 45 pts JTCVS 2001 44 pts JTCVS 2006 193 pts 30 day mortality 1-5 %

Undersized Mitral Repair Feasible Low mortality Relief of MR Better Quality of life

Mitral Repair and CHF : benefit? Yikes - No mortality benefit!

Mitral Repair and CHF : benefit? Why - No mortality benefit?

FMR : residual / recurrent MR Progression of 3 or 4+ MR post-undersized annuloplasty (585) McGee, Gillinov et al, JTCVS, 2004;128:916-24

MVR and CHF Even a good operation, when done badly will not help a sick patient! recurrent FMR is still bad

Do a Better Operation : Surgical Predictors of Recurrent MR Flexible = 5x recurrent MR! Use rigid complete! Spoor, Geltz, Bolling : Circulation, 11/06

Flexible and/or partial bands don t provide a durable solution for FMR Magne et al. Cardiology 2009;112:244-259259

Strongest predictor of recurrent MR AP dia > 3.7 cm Recurrent MR Failed Repair AP diameter reduction!!! Kongsaerepong V et al. Am J Cardiol 2006;98:504-8

IMR-FMR ring designs Disproportionate AP dimension reduction Bothe W, Swanson J, et al., JTCVS 2010

MV repair 30 day mort 1.6% 1.6% Freedom from >1+ MR = 90%!! JTCVS 2006

FMR Surgery LV reverse remodeling

Braun J, et al., Leiden Ann Thorac Surg 2008;85:430 437

FMR : Ventricular Problem!! LVEDD < 65 mm! Braun J, et al., Leiden Ann Thorac Surg 2008;85:430 437

CHF Mitral Repair - Kron

CHF Mitral Repair - Hvass J Thorac Cardiovasc Surg. 2010 Feb;139(2):418-23. The papillary muscle sling for ischemic mitral regurgitation.hvass U, Joudinaud T.

CorCap only

Randomized FMR trial JTCVS Fatouch 2009

FMR - survival

FMR exercise MR

Randomized CABG + MVr for mod IMR Mitral regurg volume - 69% vs 14% LV end systolic volumes - 24% vs 10% LV sphericity - 18% vs + 1.7 % Peak oxygen capacity + 3.0 vs 1.0 Brain natriuretic peptide - 76% vs 59% All p < 0.01! Mitral Valve Annuloplasty in Addition to Coronary Artery Bypass Grafting in Moderate Functional Ischemic Mitral Regurgitation Reverses Left Ventricular Remodelling and Restores Left Ventricular Geometry: Chan et al, CIRC March 2012

Functional MR - 2012 Rigid, complete, undersized ring: Overall 6.5 year survival 86% DeBonis et al Eur J of CVTS, April 18, 2012 134 prospective propensity matched pts CHF / severe MR Editorial : SF Bolling : Mitral repair for functional mitral regurgitation in idiopathic dilated cardiomyopathy : A good operation done well may help!

Mitral Repair and IMR Repair vs. Just Replace it!

100 High Risk 100 Medium Risk 80 80 60 60 40 20 I Worst 20%!! 0 0 1 2 3 4 5 6 7 0 0 1 2 3 4 5 6 7 40 20 II 100 Low Risk Survival 80 60 Replace Repair 40 20 0 0 III - V 1 2 3 4 5 6 7 Gillinov et al, JTCVS 2001;122:1125-41

Valve sparing replacement vs repair Survival for 4+ IMR Al Radi et al, Ann Thorac Surg, 2005;79:1260-7

Mt Sinai - High risk CABG/MVr

Severe Ischemic Mitral Regurgitation - repair vs replacement

Mitral Repair and IMR Good repair Replacement Bad repair

Catheter-Based Mitral Valve Repair MitraClip System

LV Volumes by MR Etiology Reduction in LV volumes, BUT CLIP LEAVES MR!! p<0.0001 Baseline 12 Months p=0.0005 160 153 130 160 160 143 Volume (ml) 120 80 p=0.0042 55 51 Volume (ml) 120 80 p=0.0829 82 75 40 40 0 LVEDV LVESV LVEDV LVESV Degen MR Subgroup n=88 0 FMR Device Subgroup n=30

Septal-Lateral Annular Dimension Baseline vs 12 Months, 3.9 3.8!! 6 End Systole End Diastole Dimension (cm) 5 4 3 2 p=0.6716 3.3 3.3 p=0.0163 3.9 3.8 1 0 Baseline 12 Months Baseline 12 Month n=111 n=111 p-value compares baseline to 12 month measurements within device Septal-Lateral Annular Dimension not collected in Control group due to the presence of annuloplasty ring or replacement valve

Re-Inventing a Failed Surgical technique? The Importance of Annuloplasty Annuloplasty No annuloplasty 260 pts Overall freedom reop 90% (68% without ring) Alfieri O, et al. JTCVS 2001;122:674-81

Mitraclip Functional MR Results high risk EF - 55 % 8% mort @ 30 d 25% mort @ 1 yr DMR / FMR No controls Not random Left 2-4+ MR!

50 pts > 3+ MR CRT failed - 21 Age 70; euroscore 34; LVEDD 70mm; LVEDV 252 ml; LVEF 19% Franzen et al Eur J Heart Fail 2011; 13:569-76

Mitral regurgitation at baseline, discharge and 6 months Almost half had significant Residual MR! Franzen O et al. Eur J Heart Fail 2011;13:569-576

Mitral Clip in FMR 17 % mortality! Franzen O et al. Eur J Heart Fail 2011;13:569-576

Franzen O et al. Eur J Heart Fail 2011;13:569-576 LV Remodeling??

Optimal treatment of FMR Find MR! Fix MR! OMT, CRT, Clip (COAPT)

Optimal treatment for FMR GOOD SURGERY! Careful patient selection Beware the big LV and the bad RV! Repair - use complete rigid ring Replacement - selective RCT!

FMR is still a HEADACHE!!